
Gerald R. Ewoldt
Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1060 |
| Issued Applications | 256 |
| Pending Applications | 142 |
| Abandoned Applications | 661 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6080178
[patent_doc_number] => 20110142866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'PEPTIDE ANALOGUES AND CONJUGATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/743975
[patent_app_country] => US
[patent_app_date] => 2008-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32414
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142866.pdf
[firstpage_image] =>[orig_patent_app_number] => 12743975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/743975 | PEPTIDE ANALOGUES AND CONJUGATES THEREOF | Nov 19, 2008 | Abandoned |
Array
(
[id] => 6520039
[patent_doc_number] => 20100261887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF RELAPSING MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/740421
[patent_app_country] => US
[patent_app_date] => 2008-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18710
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261887.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740421
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740421 | TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF RELAPSING MULTIPLE SCLEROSIS | Nov 10, 2008 | Abandoned |
Array
(
[id] => 8406392
[patent_doc_number] => 20120238460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'RANTES LEVELS AS A DIAGNOSTIC AND THERAPEUTIC FOR ACUTE GRAFT VERSUS HOST DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/739976
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15253
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12739976
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/739976 | RANTES LEVELS AS A DIAGNOSTIC AND THERAPEUTIC FOR ACUTE GRAFT VERSUS HOST DISEASE | Nov 9, 2008 | Abandoned |
Array
(
[id] => 6292581
[patent_doc_number] => 20100239580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF OPTIC NEURITIS'
[patent_app_type] => utility
[patent_app_number] => 12/740879
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14985
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20100239580.pdf
[firstpage_image] =>[orig_patent_app_number] => 12740879
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/740879 | TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR TREATMENT OF OPTIC NEURITIS | Nov 9, 2008 | Abandoned |
Array
(
[id] => 5342387
[patent_doc_number] => 20090181037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses'
[patent_app_type] => utility
[patent_app_number] => 12/263738
[patent_app_country] => US
[patent_app_date] => 2008-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20816
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181037.pdf
[firstpage_image] =>[orig_patent_app_number] => 12263738
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/263738 | Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses | Nov 2, 2008 | Abandoned |
Array
(
[id] => 6024243
[patent_doc_number] => 20110052569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'MOLECULES AND METHODS FOR TREATMENT OF DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/676776
[patent_app_country] => US
[patent_app_date] => 2008-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17676
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12676776
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/676776 | MOLECULES AND METHODS FOR TREATMENT OF DIABETES | Sep 5, 2008 | Abandoned |
Array
(
[id] => 5953227
[patent_doc_number] => 20110033929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'USES OF ANTIBODIES TO MAMMALIAN DC LANGERHANS CELL ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 12/202701
[patent_app_country] => US
[patent_app_date] => 2008-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23983
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033929.pdf
[firstpage_image] =>[orig_patent_app_number] => 12202701
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/202701 | USES OF ANTIBODIES TO MAMMALIAN DC LANGERHANS CELL ANTIGEN | Sep 1, 2008 | Abandoned |
Array
(
[id] => 6266440
[patent_doc_number] => 20100298227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => ' Treatment of autoimmune conditions with Copolymer 1 and related copolymers'
[patent_app_type] => utility
[patent_app_number] => 12/231292
[patent_app_country] => US
[patent_app_date] => 2008-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17544
[patent_no_of_claims] => 176
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298227.pdf
[firstpage_image] =>[orig_patent_app_number] => 12231292
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/231292 | Treatment of autoimmune conditions with Copolymer 1 and related copolymers | Aug 28, 2008 | Abandoned |
Array
(
[id] => 6402926
[patent_doc_number] => 20100179307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'BIOMAKER COMPOSITION FOR DETECTING DIABETIC RETINOPATHY AND DIAGNOSTIC KIT THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/733330
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19381
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179307.pdf
[firstpage_image] =>[orig_patent_app_number] => 12733330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733330 | BIOMAKER COMPOSITION FOR DETECTING DIABETIC RETINOPATHY AND DIAGNOSTIC KIT THEREFOR | Aug 27, 2008 | Abandoned |
Array
(
[id] => 5323485
[patent_doc_number] => 20090061475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Methods for Identifying Compounds for the Treatment of Type 1 Diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/196543
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7029
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20090061475.pdf
[firstpage_image] =>[orig_patent_app_number] => 12196543
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/196543 | Methods for Identifying Compounds for the Treatment of Type 1 Diabetes | Aug 21, 2008 | Abandoned |
Array
(
[id] => 4778283
[patent_doc_number] => 20080286281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'CD25 BINDING MOLECULES FOR THE USE IN THE TREATMENT OF MANIFESTATIONS OF REJECTION IN TRANSPLANTATION'
[patent_app_type] => utility
[patent_app_number] => 12/180660
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2468
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286281.pdf
[firstpage_image] =>[orig_patent_app_number] => 12180660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/180660 | CD25 BINDING MOLECULES FOR THE USE IN THE TREATMENT OF MANIFESTATIONS OF REJECTION IN TRANSPLANTATION | Jul 27, 2008 | Abandoned |
Array
(
[id] => 5441413
[patent_doc_number] => 20090093052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Human Hematopoietic Stem And Progenitor Antigen And Methods For Its Use'
[patent_app_type] => utility
[patent_app_number] => 12/169336
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14452
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093052.pdf
[firstpage_image] =>[orig_patent_app_number] => 12169336
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/169336 | Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment | Jul 7, 2008 | Issued |
Array
(
[id] => 10882006
[patent_doc_number] => 08906383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'T cell receptor having binding affinity for a peptide-MHC complex and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/666416
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 17
[patent_no_of_words] => 15062
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12666416
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666416 | T cell receptor having binding affinity for a peptide-MHC complex and uses thereof | Jun 26, 2008 | Issued |
Array
(
[id] => 5575430
[patent_doc_number] => 20090142792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Biomarkers for the diagnosis of autoimmune disease'
[patent_app_type] => utility
[patent_app_number] => 12/214670
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22026
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142792.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214670
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214670 | Biomarkers for the diagnosis of autoimmune disease | Jun 19, 2008 | Abandoned |
Array
(
[id] => 6228859
[patent_doc_number] => 20100183597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'DRAK2 EXPRESSION IS ASSOCIATED WITH DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/602893
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 25834
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183597.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602893
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602893 | DRAK2 EXPRESSION IS ASSOCIATED WITH DIABETES | Jun 5, 2008 | Abandoned |
Array
(
[id] => 5507920
[patent_doc_number] => 20090081127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response'
[patent_app_type] => utility
[patent_app_number] => 12/154939
[patent_app_country] => US
[patent_app_date] => 2008-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17891
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081127.pdf
[firstpage_image] =>[orig_patent_app_number] => 12154939
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/154939 | Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response | May 26, 2008 | Abandoned |
Array
(
[id] => 6479316
[patent_doc_number] => 20100285146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'PEPTIDES AND METHODS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS'
[patent_app_type] => utility
[patent_app_number] => 12/601261
[patent_app_country] => US
[patent_app_date] => 2008-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 7697
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285146.pdf
[firstpage_image] =>[orig_patent_app_number] => 12601261
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601261 | PEPTIDES AND METHODS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS | May 21, 2008 | Abandoned |
Array
(
[id] => 6577282
[patent_doc_number] => 20100047273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Coxsackie B virus and type 1 diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/151725
[patent_app_country] => US
[patent_app_date] => 2008-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11969
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047273.pdf
[firstpage_image] =>[orig_patent_app_number] => 12151725
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/151725 | Coxsackie B virus and type 1 diabetes | May 6, 2008 | Abandoned |
Array
(
[id] => 13635305
[patent_doc_number] => 09844602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Antibody and use in diagnosis and therapy of arthropathies
[patent_app_type] => utility
[patent_app_number] => 12/598671
[patent_app_country] => US
[patent_app_date] => 2008-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9819
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12598671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598671 | Antibody and use in diagnosis and therapy of arthropathies | May 1, 2008 | Issued |
Array
(
[id] => 6550509
[patent_doc_number] => 20100233183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/598128
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8135
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598128
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598128 | CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE | Apr 29, 2008 | Abandoned |